Article
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
Current treatment options in oncology - 23 Aug 2021
Romero Atocha, Serna-Blasco Roberto, Calvo Virginia, Provencio Mariano
Abstract excerpt
OPINION STATEMENT: Recent technological advances have enabled the development of liquid biopsy-based approaches, which have revolutionized the diagnostic world. The analysis of circulating tumor DNA (ctDNA) has several clinical applications. First, ctDNA genotyping is becoming widely used for non-invasive biomarker testing. Of note, in lung cancer patients in whom biopsies are difficult to obtain, ctDNA has led...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
